Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic Excellence
Agency: National Institutes of Health
- 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Forecasted opportunityLast Updated: Sep 10, 2026
Important dates
- Forecasted post date: March 25, 2027
- Forecasted application due date: May 25, 2027
- Forecasted award date: April 25, 2028
- Forecasted project start date: April 25, 2028
- Fiscal Year: 2028
Award details
- Expected project funding: Not specified
- Expected awards: Not specified
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:PAR-27-137
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: September 10, 2026
- Archive date: Not specified
- Version: 1
Summary
NINDS intends to support multiple clinical Networks of Diagnostic Excellence (NODEs) as part of the next phase of the Undiagnosed Diseases Network (UDN). Unlike prior phases, clinical NODEs are expected to function as geographically distributed regional clinical networks rather than single-site centers. Each clinical NODE would establish and lead a regional network built on existing partnerships with academic medical centers, hospitals, clinics, federally qualified health centers, and other community-based clinical partners to broaden access to specialized diagnostic expertise and extend the reach of the UDN.
Clinical NODEs are expected to provide a coordinated, multidisciplinary and participant-centered evaluation of individuals with highly challenging, difficult-to-diagnose conditions. In collaboration with the Network, clinical NODEs will recruit and enroll participants, conduct medical record reviews, make enrollment determinations, communicate review outcomes and recommendations to participants and referring providers, and coordinate the clinical evaluation with local partner sites and referring providers, as appropriate.
In addition, clinical NODEs will participate in network collaborations to develop and test innovative, new diagnostic tools and strategies for both genomic and non-genomic conditions, support systematic re-evaluation of unsolved UDN cases, and conduct research to optimize participant access and experience. Clinical NODEs are also expected to participate in network governance and infrastructure; provide training to support consistent implementation of UDN processes and standards; incorporate participant and community input into workflows and engagement strategies, such as through a Community Advisory Board or comparable mechanisms; and monitor site performance.
Applications are not being solicited at this time. This Forecast is being published to provide potential applicants time to plan, establish collaborations, formalize regional partnerships, and prepare responsive projects.
Eligibility
Government
- County governments
- State governments
- Federally recognized Native American tribal governments
- Special district governments
- City or township governments
- Public and Indian housing authorities
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
Education
- Independent school districts
- Private institutions of higher education
- Public and state institutions of higher education
Miscellaneous
- Other
Business
- Small businesses
- For-profit organizations other than small businesses
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: UDNProgramStaff@ninds.nih.gov
UDNProgramStaff@ninds.nih.gov
Link to additional information
No additional information is available
